Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - Orchid Island Capital, Inc. | orc10q20200331x322.htm |
EX-32.1 - EXHIBIT 32.1 - Orchid Island Capital, Inc. | orc10q20200331x321.htm |
EX-31.2 - EXHIBIT 31.2 - Orchid Island Capital, Inc. | orc10q20200331x312.htm |
EX-31.1 - EXHIBIT 31.1 - Orchid Island Capital, Inc. | orc10q20200331x311.htm |
EX-10.1 - EXHIBIT 10.1 - Orchid Island Capital, Inc. | orc10q20200331x101.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to ___________
Commission File Number: 001-35236
Orchid Island Capital, Inc.
(Exact name of registrant as specified in its charter)
Maryland
|
27-3269228
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
3305 Flamingo Drive, Vero Beach, Florida 32963
(Address of principal executive offices) (Zip Code)
(772) 231-1400
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
|
Trading Symbol:
|
Name of Each Exchange on Which Registered
|
Common Stock, $0.01 par value
|
ORC
|
New York Stock Exchange
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ◻
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No ◻
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the
definitions of "large accelerated filer," "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act. Check one:
Large accelerated filer
|
◻
|
Accelerated filer
|
⌧
|
Non-accelerated filer
|
◻
|
Smaller reporting company
|
◻
|
|
|
Emerging growth company
|
◻
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act. ◻
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ◻ No ý
Number of shares outstanding at May 1, 2020: 66,236,639
ORCHID ISLAND CAPITAL, INC.
TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION
|
|
ITEM 1. Financial Statements
|
1
|
Condensed Balance Sheets (unaudited)
|
1
|
Condensed Statements of Operations (unaudited)
|
2
|
Condensed Statement of Stockholders’ Equity (unaudited)
|
3
|
Condensed Statements of Cash Flows (unaudited)
|
4
|
Notes to Condensed Financial Statements
|
5
|
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
23
|
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk
|
43
|
ITEM 4. Controls and Procedures
|
47
|
PART II. OTHER INFORMATION
|
|
ITEM 1. Legal Proceedings
|
48
|
ITEM 1A. Risk Factors
|
48
|
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
50
|
ITEM 3. Defaults upon Senior Securities
|
50
|
ITEM 4. Mine Safety Disclosures
|
50
|
ITEM 5. Other Information
|
50
|
ITEM 6. Exhibits
|
51
|
SIGNATURES
|
52
|
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
ORCHID ISLAND CAPITAL, INC.
|
||||||||
CONDENSED BALANCE SHEETS
|
||||||||
($ in thousands, except per share data)
|
||||||||
(Unaudited)
|
||||||||
March 31, 2020
|
December 31, 2019
|
|||||||
ASSETS:
|
||||||||
Mortgage-backed securities, at fair value
|
||||||||
Pledged to counterparties
|
$
|
2,937,749
|
$
|
3,584,354
|
||||
Unpledged
|
11,048
|
6,567
|
||||||
Total mortgage-backed securities
|
2,948,797
|
3,590,921
|
||||||
Cash and cash equivalents
|
162,725
|
193,770
|
||||||
Restricted cash
|
38,725
|
84,885
|
||||||
Accrued interest receivable
|
10,054
|
12,404
|
||||||
Derivative assets, at fair value
|
1,336
|
-
|
||||||
Other assets
|
755
|
100
|
||||||
Total Assets
|
$
|
3,162,392
|
$
|
3,882,080
|
||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
LIABILITIES:
|
||||||||
Repurchase agreements
|
$
|
2,810,250
|
$
|
3,448,106
|
||||
Payable for unsettled securities purchased
|
3,450
|
-
|
||||||
Dividends payable
|
5,299
|
5,045
|
||||||
Derivative liabilities, at fair value
|
30,097
|
20,658
|
||||||
Accrued interest payable
|
3,814
|
11,101
|
||||||
Due to affiliates
|
520
|
622
|
||||||
Other liabilities
|
818
|
1,041
|
||||||
Total Liabilities
|
2,854,248
|
3,486,573
|
||||||
COMMITMENTS AND CONTINGENCIES
|
||||||||
STOCKHOLDERS' EQUITY:
|
||||||||
Preferred stock, $0.01 par value; 100,000,000 shares authorized; no shares issued
|
||||||||
and outstanding as of March 31, 2020 and December 31, 2019
|
-
|
-
|
||||||
Common Stock, $0.01 par value; 500,000,000 shares authorized, 66,236,639
|
||||||||
shares issued and outstanding as of March 31, 2020 and 63,061,781 shares issued
|
||||||||
and outstanding as of December 31, 2019
|
662
|
631
|
||||||
Additional paid-in capital
|
418,803
|
414,998
|
||||||
Accumulated deficit
|
(111,321
|
)
|
(20,122
|
)
|
||||
Total Stockholders' Equity
|
308,144
|
395,507
|
||||||
Total Liabilities and Stockholders' Equity
|
$
|
3,162,392
|
$
|
3,882,080
|
||||
See Notes to Financial Statements
|
1
ORCHID ISLAND CAPITAL, INC.
|
||||||||
CONDENSED STATEMENTS OF OPERATIONS
|
||||||||
(Unaudited)
|
||||||||
For the Three Months Ended March 31, 2020 and 2019
|
||||||||
($ in thousands, except per share data)
|
||||||||
Three Months Ended March 31,
|
||||||||
2020
|
2019
|
|||||||
Interest income
|
$
|
35,671
|
$
|
32,433
|
||||
Interest expense
|
(16,523
|
)
|
(18,892
|
)
|
||||
Net interest income
|
19,148
|
13,541
|
||||||
Realized (losses) gains on mortgage-backed securities
|
(28,380
|
)
|
243
|
|||||
Unrealized gains on mortgage-backed securities
|
3,032
|
18,041
|
||||||
Losses on derivative instruments
|
(82,858
|
)
|
(19,032
|
)
|
||||
Net portfolio (loss) income
|
(89,058
|
)
|
12,793
|
|||||
Expenses:
|
||||||||
Management fees
|
1,377
|
1,285
|
||||||
Allocated overhead
|
347
|
323
|
||||||
Accrued incentive compensation
|
(436
|
)
|
(408
|
)
|
||||
Directors' fees and liability insurance
|
260
|
253
|
||||||
Audit, legal and other professional fees
|
255
|
301
|
||||||
Direct REIT operating expenses
|
206
|
375
|
||||||
Other administrative
|
132
|
67
|
||||||
Total expenses
|
2,141
|
2,196
|
||||||
Net (loss) income
|
$
|
(91,199
|
)
|
$
|
10,597
|
|||
Basic and diluted net (loss) income per share
|
$
|
(1.41
|
)
|
$
|
0.22
|
|||
Weighted Average Shares Outstanding
|
64,590,205
|
48,904,587
|
||||||
Dividends declared per common share
|
$
|
0.24
|
$
|
0.24
|
||||
See Notes to Financial Statements
|
2
ORCHID ISLAND CAPITAL, INC.
|
||||||||||||||||||||
CONDENSED STATEMENT OF STOCKHOLDERS' EQUITY
|
||||||||||||||||||||
(Unaudited)
|
||||||||||||||||||||
For the Three Months Ended March 31, 2020 and 2019
|
||||||||||||||||||||
(in thousands)
|
||||||||||||||||||||
Additional
|
Retained
|
|||||||||||||||||||
Common Stock
|
Paid-in
|
Earnings
|
||||||||||||||||||
Shares
|
Par Value
|
Capital
|
(Deficit)
|
Total
|
||||||||||||||||
Balances, January 1, 2019
|
49,132
|
$
|
491
|
$
|
379,975
|
$
|
(44,387
|
)
|
$
|
336,079
|
||||||||||
Net income
|
-
|
-
|
-
|
10,597
|
10,597
|
|||||||||||||||
Cash dividends declared
|
-
|
-
|
(11,822
|
)
|
-
|
(11,822
|
)
|
|||||||||||||
Issuance of common stock pursuant to public offerings, net
|
1,268
|
13
|
8,490
|
-
|
8,503
|
|||||||||||||||
Issuance of common stock pursuant to stock based
|
||||||||||||||||||||
compensation plan
|
7
|
-
|
(6
|
)
|
-
|
(6
|
)
|
|||||||||||||
Amortization of stock based compensation
|
-
|
-
|
87
|
-
|
87
|
|||||||||||||||
Shares repurchased and retired
|
(469
|
)
|
(5
|
)
|
(3,019
|
)
|
-
|
(3,024
|
)
|
|||||||||||
Balances, March 31, 2019
|
49,938
|
$
|
499
|
$
|
373,705
|
$
|
(33,790
|
)
|
$
|
340,414
|
||||||||||
Balances, January 1, 2020
|
63,062
|
$
|
631
|
$
|
414,998
|
$
|
(20,122
|
)
|
$
|
395,507
|
||||||||||
Net loss
|
-
|
-
|
-
|
(91,199
|
)
|
(91,199
|
)
|
|||||||||||||
Cash dividends declared
|
-
|
-
|
(15,670
|
)
|
-
|
(15,670
|
)
|
|||||||||||||
Issuance of common stock pursuant to public offerings, net
|
3,171
|
31
|
19,416
|
-
|
19,447
|
|||||||||||||||
Issuance of common stock pursuant to stock based
|
||||||||||||||||||||
compensation plan
|
4
|
-
|
-
|
-
|
-
|
|||||||||||||||
Amortization of stock based compensation
|
-
|
-
|
59
|
-
|
59
|
|||||||||||||||
Balances, March 31, 2020
|
66,237
|
$
|
662
|
$
|
418,803
|
$
|
(111,321
|
)
|
$
|
308,144
|
||||||||||
See Notes to Financial Statements
|
3
ORCHID ISLAND CAPITAL, INC.
|
||||||||
CONDENSED STATEMENTS OF CASH FLOWS
|
||||||||
(Unaudited)
|
||||||||
For the Three Months Ended March 31, 2020 and 2019
|
||||||||
($ in thousands)
|
||||||||
2020
|
2019
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net (loss) income
|
$
|
(91,199
|
)
|
$
|
10,597
|
|||
Adjustments to reconcile net (loss) income to net cash used in operating activities:
|
||||||||
Stock based compensation
|
59
|
87
|
||||||
Realized and unrealized losses (gains) on mortgage-backed securities
|
25,348
|
(18,284
|
)
|
|||||
Realized and unrealized losses on interest rate swaptions
|
2,589
|
378
|
||||||
Realized and unrealized losses on interest rate swaps
|
54,934
|
2,522
|
||||||
Realized losses on forward settling to-be-announced securities
|
7,090
|
4,641
|
||||||
Changes in operating assets and liabilities:
|
||||||||
Accrued interest receivable
|
2,350
|
696
|
||||||
Other assets
|
(655
|
)
|
(339
|
)
|
||||
Accrued interest payable
|
(7,287
|
)
|
(1,299
|
)
|
||||
Other liabilities
|
(223
|
)
|
(477
|
)
|
||||
Due from affiliates
|
(102
|
)
|
(113
|
)
|
||||
NET CASH USED IN OPERATING ACTIVITIES
|
(7,096
|
)
|
(1,591
|
)
|
||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
From mortgage-backed securities investments:
|
||||||||
Purchases
|
(1,334,350
|
)
|
(547,417
|
)
|
||||
Sales
|
1,808,867
|
655,359
|
||||||
Principal repayments
|
142,259
|
94,785
|
||||||
Payments on net settlement of to-be-announced securities
|
(7,602
|
)
|
(11,146
|
)
|
||||
Purchase of derivative financial instruments, net of margin cash received
|
(45,458
|
)
|
(8,723
|
)
|
||||
NET CASH PROVIDED BY INVESTING ACTIVITIES
|
563,716
|
182,858
|
||||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Proceeds from repurchase agreements
|
13,602,710
|
11,573,937
|
||||||
Principal payments on repurchase agreements
|
(14,240,566
|
)
|
(11,732,251
|
)
|
||||
Cash dividends
|
(15,416
|
)
|
(11,758
|
)
|
||||
Proceeds from issuance of common stock, net of issuance costs
|
19,447
|
8,503
|
||||||
Common stock repurchases
|
-
|
(3,030
|
)
|
|||||
NET CASH USED IN FINANCING ACTIVITIES
|
(633,825
|
)
|
(164,599
|
)
|
||||
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
|
(77,205
|
)
|
16,668
|
|||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of the period
|
278,655
|
126,263
|
||||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of the period
|
$
|
201,450
|
$
|
142,931
|
||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||
Cash paid during the period for:
|
||||||||
Interest
|
$
|
23,809
|
$
|
20,190
|
||||
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING ACTIVITIES:
|
||||||||
Securities acquired settled in later period
|
$
|
3,450
|
$
|
35,026
|
||||
See Notes to Financial Statements
|
4
ORCHID ISLAND CAPITAL, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
MARCH 31, 2020
NOTE 1. ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES
Organization and Business Description
Orchid Island Capital, Inc. (“Orchid” or the “Company”), was incorporated in Maryland on August 17, 2010 for the purpose of creating and managing a leveraged investment portfolio consisting of residential mortgage-backed
securities (“RMBS”). From incorporation to February 20, 2013, Orchid was a wholly owned subsidiary of Bimini Capital Management, Inc. (“Bimini”). Orchid began operations on November 24, 2010 (the date of commencement of operations). From
incorporation through November 24, 2010, Orchid’s only activity was the issuance of common stock to Bimini.
On August 2, 2017, Orchid entered into an equity distribution agreement (the “August 2017 Equity Distribution Agreement”) with two sales agents pursuant to which the Company could offer and sell, from time to time, up to
an aggregate amount of $125,000,000 of shares of the Company’s common stock in transactions that were deemed to be “at the market” offerings and privately negotiated transactions. The Company issued a total of 15,123,178 shares under the August 2017
Equity Distribution Agreement for aggregate gross proceeds of approximately $125.0 million, and net proceeds of approximately $123.1 million, net of commissions and fees, prior to its termination in July 2019.
On July 30, 2019, Orchid entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the
underwriters named therein, relating to the offer and sale of 7,000,000 shares of the Company’s common stock at a price to the public of $6.55 per share. The underwriters purchased the shares pursuant to the Underwriting Agreement at a price of
$6.3535 per share. The closing of the offering of 7,000,000 shares of common stock occurred on August 2, 2019, with net proceeds to the Company of approximately $44.2 million after deduction of underwriting discounts and commissions and other
estimated offering expenses.
On January 23, 2020, Orchid entered into an equity distribution agreement (the “January 2020 Equity Distribution Agreement”) with three sales agents pursuant to which the Company may offer and sell, from time to time, up
to an aggregate amount of $200,000,000 of shares of the Company’s common stock in transactions that are deemed to be “at the market” offerings and privately negotiated transactions. Through March 31, 2020, the Company issued a total of 3,170,727
shares under the January 2020 Equity Distribution Agreement for aggregate gross proceeds of approximately $19.8 million, and net proceeds of approximately $19.4 million, net of commissions and fees.
COVID-19 Impact
Beginning in mid-March 2020, the global pandemic associated with the novel coronavirus COVID-19 (“COVID-19”) and related economic conditions began to impact our financial position and results of operations. As a result
of the economic, health and market turmoil brought about by COVID-19, the Agency RMBS market experienced severe dislocations. This resulted in falling prices of our assets and increased margin calls from our repurchase agreement lenders. In order to
maintain sufficient cash and liquidity, reduce risk and satisfy margin calls, we were forced to sell assets at levels significantly below their carrying values. We timely satisfied all margin calls. The Agency RMBS market largely stabilized after the
Federal Reserve announced on March 23, 2020 that it would purchase Agency RMBS and U.S. Treasuries in the amounts needed to support smooth market functioning. The following summarizes the impact COVID-19 has had on our financial position and results
of operations through March 31, 2020.
5
•
|
We sold approximately $1.8 billion of RMBS during the three months ended March 31, 2020, realizing losses of approximately $28.4 million. Approximately $1.1 billion of these sales were executed on March 19th and March 20th and resulted
in losses of approximately $31.4 million. The losses sustained on these two days were a direct result of the adverse RMBS market conditions associated with COVID-19.
|
•
|
We terminated interest rate swap positions with an aggregate notional value of $860.0 million and incurred approximately $45.0 million in mark to market losses on the positions through the date of the respective terminations.
|
•
|
Our RMBS portfolio had a fair market value of approximately $2.9 billion as of March 31, 2020, compared to $3.6 billion as of December 31, 2019.
|
•
|
Our outstanding balances under our repurchase agreement borrowings as of March 31, 2020 were approximately $2.8 billion, compared to $3.4 billion as of December 31, 2019.
|
•
|
Our stockholders’ equity was $308.1 million as of March 31, 2020, compared to $395.5 million as of December 31, 2019.
|
In response to the Shelter in Place order issued in Florida, our manager has invoked its Disaster Recovery Plan and its employees are working remotely. Prior planning resulted in the successful implementation of this
plan and key operational team members maintain daily communication.
Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it may continue to have adverse effects on the Company’s results of future
operations, financial position, and liquidity in fiscal year 2020.
In addition, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security (CARES) Act, which will provide billions of dollars of relief to individuals, businesses, state and local governments, and
the health care system suffering the impact of the pandemic, including mortgage loan forbearance and modification programs to qualifying borrowers who may have difficulty making their loan payments. The Company has evaluated the provisions of the
CARES Act and does not believe it will have material effect on the financial statements.The Federal Housing Financing Agency (the “FHFA”) has instructed the GSEs on how they will handle servicer advances for loans that back Agency RMBS that enter
into forbearance, which should limit prepayments during the forbearance period that could have resulted otherwise. There can be no assurance as to how, in the long term, these and other actions by the U.S. government will affect the efficiency,
liquidity and stability of the financial and mortgage markets. To the extent the financial or mortgage markets do not respond favorably to any of these actions, or such actions do not function as intended, our business, results of operations and
financial condition may continue to be materially adversely affected.
Basis of Presentation and Use of Estimates
The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to
Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring
accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.
The balance sheet at December 31, 2019 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements.
For further information, refer to the financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.
6
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The significant estimates affecting the accompanying financial
statements are the fair values of RMBS and derivatives. Management believes the estimates and assumptions underlying the financial statements are reasonable based on the information available as of March 31, 2020, however uncertainty over the
ultimate impact that COVID-19 will have on the global economy generally, and on Orchid’s business in particular, makes any estimates and assumptions as of March 31, 2020 inherently less certain than they would be absent the current and potential
impacts of COVID-19.
Variable Interest Entities (“VIEs”)
We obtain interests in VIEs through our investments in mortgage-backed securities. Our interests in these VIEs are passive in nature and are not expected to result in us obtaining a controlling financial interest in
these VIEs in the future. As a result, we do not consolidate these VIEs and we account for our interest in these VIEs as mortgage-backed securities. See Note 2 for additional information regarding our investments in mortgage-backed securities. Our
maximum exposure to loss for these VIEs is the carrying value of the mortgage-backed securities.
Cash and Cash Equivalents and Restricted Cash
Cash and cash equivalents include cash on deposit with financial institutions and highly liquid investments with original maturities of three months or less at the time of purchase. Restricted cash includes cash pledged
as collateral for repurchase agreements and other borrowings, and interest rate swaps and other derivative instruments.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of
cash flows.
(in thousands)
|
||||||||
March 31, 2020
|
December 31, 2019
|
|||||||
Cash and cash equivalents
|
$
|
162,725
|
$
|
193,770
|
||||
Restricted cash
|
38,725
|
84,885
|
||||||
Total cash, cash equivalents and restricted cash
|
$
|
201,450
|
$
|
278,655
|
The Company maintains cash balances at three banks and excess margin on account with two exchange clearing members. At times, balances may exceed federally insured limits. The Company has not experienced any losses
related to these balances. The Federal Deposit Insurance Corporation insures eligible accounts up to $250,000 per depositor at each financial institution. Restricted cash balances are uninsured, but are held in separate customer accounts that are
segregated from the general funds of the counterparty. The Company limits uninsured balances to only large, well-known banks and exchange clearing members and believes that it is not exposed to any significant credit risk on cash and cash
equivalents or restricted cash balances.
7
Mortgage-Backed Securities
The Company invests primarily in mortgage pass-through (“PT”) residential mortgage backed certificates issued by Freddie Mac, Fannie Mae or Ginnie Mae (“RMBS”), collateralized mortgage obligations (“CMOs”), interest-only
(“IO”) securities and inverse interest-only (“IIO”) securities representing interest in or obligations backed by pools of RMBS. We refer to RMBS and CMOs as PT RMBS. We refer to IO and IIO securities as structured RMBS. The Company has elected to
account for its investment in RMBS under the fair value option. Electing the fair value option requires the Company to record changes in fair value in the statement of operations, which, in management’s view, more appropriately reflects the results
of our operations for a particular reporting period and is consistent with the underlying economics and how the portfolio is managed.
The Company records RMBS transactions on the trade date. Security purchases that have not settled as of the balance sheet date are included in the RMBS balance with an offsetting liability recorded, whereas securities
sold that have not settled as of the balance sheet date are removed from the RMBS balance with an offsetting receivable recorded.
Fair value is defined as the price that would be received to sell the asset or paid to transfer the liability in an orderly transaction between market participants at the measurement date. The fair value measurement
assumes that the transaction to sell the asset or transfer the liability either occurs in the principal market for the asset or liability, or in the absence of a principal market, occurs in the most advantageous market for the asset or liability.
Estimated fair values for RMBS are based on independent pricing sources and/or third party broker quotes, when available.
Income on PT RMBS securities is based on the stated interest rate of the security. Premiums or discounts present at the date of purchase are not amortized. Premium lost and discount accretion resulting from monthly
principal repayments are reflected in unrealized gains (losses) on RMBS in the statements of operations. For IO securities, the income is accrued based on the carrying value and the effective yield. The difference between income accrued and the
interest received on the security is characterized as a return of investment and serves to reduce the asset’s carrying value. At each reporting date, the effective yield is adjusted prospectively for future reporting periods based on the new estimate
of prepayments and the contractual terms of the security. For IIO securities, effective yield and income recognition calculations also take into account the index value applicable to the security. Changes in fair value of RMBS during each reporting
period are recorded in earnings and reported as unrealized gains or losses on mortgage-backed securities in the accompanying statements of operations.
Derivative Financial Instruments
The Company uses derivative instruments to manage interest rate risk, facilitate asset/liability strategies and manage other exposures, and it may continue to do so in the future. The principal instruments that the
Company has used to date are Treasury Note (“T-Note”), Fed Funds and Eurodollar futures contracts, interest rate swaps, options to enter in interest rate swaps (“interest rate swaptions”) and “to-be-announced” (“TBA”) securities transactions, but the
Company may enter into other derivative instruments in the future.
The Company accounts for TBA securities as derivative instruments. Gains and losses associated with TBA securities transactions are reported in gain (loss) on derivative instruments in the accompanying statements of
operations.
Derivative instruments are carried at fair value, and changes in fair value are recorded in earnings for each period. The Company’s derivative financial instruments are not designated as hedge accounting relationships,
but rather are used as economic hedges of its portfolio assets and liabilities.
8
Holding derivatives creates exposure to credit risk related to the potential for failure on the part of counterparties and exchanges to honor their commitments. In addition, the Company may be required to post
collateral based on any declines in the market value of the derivatives. In the event of default by a counterparty, the Company may have difficulty recovering its collateral and may not receive payments provided for under the terms of the
agreement. To mitigate this risk, the Company uses only well-established commercial banks and exchanges as counterparties.
Financial Instruments
The fair value of financial instruments for which it is practicable to estimate that value is disclosed either in the body of the financial statements or in the accompanying notes. RMBS, Eurodollar, Fed Funds and T-Note
futures contracts, interest rate swaps, interest rate swaptions and TBA securities are accounted for at fair value in the balance sheets. The methods and assumptions used to estimate fair value for these instruments are presented in Note 12 of the
financial statements.
The estimated fair value of cash and cash equivalents, restricted cash, accrued interest receivable, receivable for securities sold, other assets, due to affiliates, repurchase agreements, payable for unsettled
securities purchased, accrued interest payable and other liabilities generally approximates their carrying values as of March 31, 2020 and December 31, 2019 due to the short-term nature of these financial instruments.
Repurchase Agreements
The Company finances the acquisition of the majority of its RMBS through the use of repurchase agreements under master repurchase agreements. Repurchase agreements are accounted for as collateralized financing
transactions, which are carried at their contractual amounts, including accrued interest, as specified in the respective agreements.
Manager Compensation
The Company is externally managed by Bimini Advisors, LLC (the “Manager” or “Bimini Advisors”), a Maryland limited liability company and wholly-owned subsidiary of Bimini. The Company’s management agreement with the
Manager provides for payment to the Manager of a management fee and reimbursement of certain operating expenses, which are accrued and expensed during the period for which they are earned or incurred. Refer to Note 13 for the terms of the management
agreement.
Earnings Per Share
Basic earnings per share (“EPS”) is calculated as net income or loss attributable to common stockholders divided by the weighted average number of shares of common stock outstanding or subscribed during the period.
Diluted EPS is calculated using the treasury stock or two-class method, as applicable, for common stock equivalents, if any. However, the common stock equivalents are not included in computing diluted EPS if the result is anti-dilutive.
Income Taxes
Orchid has qualified and elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). REITs are generally not subject to federal income tax on their
REIT taxable income provided that they distribute to their stockholders at least 90% of their REIT taxable income on an annual basis. In addition, a REIT must meet other provisions of the Code to retain its tax status.
Orchid assesses the likelihood, based on their technical merit, that uncertain tax positions will be sustained upon examination based on the facts, circumstances and information available at the end of each period. All
of Orchid’s tax positions are categorized as highly certain. There is no accrual for any tax, interest or penalties related to Orchid’s tax position assessment. The measurement of uncertain tax positions is adjusted when new information is
available, or when an event occurs that requires a change.
9
Recent Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of
Credit Losses on Financial Instruments. ASU 2016-13 requires credit losses on most financial assets measured at amortized cost and certain other instruments to be measured using an expected credit loss model (referred to as the current
expected credit loss model). ASU 2016-13 is effective for fiscal years, and for interim periods within those years, beginning after December 15, 2019. The Company’s adoption of this ASU did not have a material effect on its financial statements as
its financial assets were already measured at fair value through earnings.
In March 2020, the FASB issued ASU 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” ASU 2020-04 provides
optional expedients and exceptions to GAAP requirements for modifications on debt instruments, leases, derivatives, and other contracts, related to the expected market transition from LIBOR, and certain other floating rate benchmark indices, or
collectively, IBORs, to alternative reference rates. ASU 2020-04 generally considers contract modifications related to reference rate reform to be an event that does not require contract remeasurement at the modification date nor a reassessment of a
previous accounting determination. The guidance in ASU 2020-04 is optional and may be elected over time, through December 31, 2022, as reference rate reform activities occur. The Company does not believe the adoption of this ASU will have a material
impact on its consolidated financial statements.
NOTE 2. MORTGAGE-BACKED SECURITIES
The following table presents the Company’s RMBS portfolio as of March 31, 2020 and December 31, 2019:
(in thousands)
|
||||||||
March 31, 2020
|
December 31, 2019
|
|||||||
Pass-Through RMBS Certificates:
|
||||||||
Adjustable-rate Mortgages
|
$
|
984
|
$
|
1,014
|
||||
Fixed-rate Mortgages
|
2,734,310
|
3,206,013
|
||||||
Fixed-rate CMOs
|
173,409
|
299,205
|
||||||
Total Pass-Through Certificates
|
2,908,703
|
3,506,232
|
||||||
Structured RMBS Certificates:
|
||||||||
Interest-Only Securities
|
40,094
|
60,986
|
||||||
Inverse Interest-Only Securities
|
-
|
23,703
|
||||||
Total Structured RMBS Certificates
|
40,094
|
84,689
|
||||||
Total
|
$
|
2,948,797
|
$
|
3,590,921
|
NOTE 3. REPURCHASE AGREEMENTS AND OTHER BORROWINGS
The Company pledges certain of its RMBS as collateral under repurchase agreements with financial institutions. Interest rates are generally fixed based on prevailing rates corresponding to the terms of the borrowings,
and interest is generally paid at the termination of a borrowing. If the fair value of the pledged securities declines, lenders will typically require the Company to post additional collateral or pay down borrowings to re-establish agreed upon
collateral requirements, referred to as "margin calls." Similarly, if the fair value of the pledged securities increases, lenders may release collateral back to the Company. As of March 31, 2020, the Company had met all margin call requirements.
10
As of March 31, 2020 and December 31, 2019, the Company’s repurchase agreements had remaining maturities as summarized below:
($ in thousands)
|
||||||||||||||||||||
OVERNIGHT
|
BETWEEN 2
|
BETWEEN 31
|
GREATER
|
|||||||||||||||||
(1 DAY OR
|
AND
|
AND
|
THAN
|
|||||||||||||||||
LESS)
|
30 DAYS
|
90 DAYS
|
90 DAYS
|
TOTAL
|
||||||||||||||||
March 31, 2020
|
||||||||||||||||||||
Fair market value of securities pledged, including
|
||||||||||||||||||||
accrued interest receivable
|
$
|
-
|
$
|
1,856,721
|
$
|
1,090,882
|
$
|
-
|
$
|
2,947,603
|
||||||||||
Repurchase agreement liabilities associated with
|
||||||||||||||||||||
these securities
|
$
|
-
|
$
|
1,768,968
|
$
|
1,041,282
|
$
|
-
|
$
|
2,810,250
|
||||||||||
Net weighted average borrowing rate
|
-
|
1.11
|
%
|
1.76
|
%
|
-
|
1.35
|
%
|
||||||||||||
December 31, 2019
|
||||||||||||||||||||
Fair market value of securities pledged, including
|
||||||||||||||||||||
accrued interest receivable
|
$
|
-
|
$
|
2,470,263
|
$
|
1,005,517
|
$
|
120,941
|
$
|
3,596,721
|
||||||||||
Repurchase agreement liabilities associated with
|
||||||||||||||||||||
these securities
|
$
|
-
|
$
|
2,361,378
|
$
|
964,368
|
$
|
122,360
|
$
|
3,448,106
|
||||||||||
Net weighted average borrowing rate
|
-
|
2.04
|
%
|
1.94
|
%
|
2.60
|
%
|
2.03
|
%
|
In addition, cash pledged to counterparties for repurchase agreements was approximately $22.2 million and $65.9 million as of March 31, 2020 and December 31, 2019, respectively.
If, during the term of a repurchase agreement, a lender files for bankruptcy, the Company might experience difficulty recovering its pledged assets, which could result in an unsecured claim against the lender for the
difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged to such lender, including the accrued interest receivable and cash posted by the Company as collateral. At March
31, 2020, the Company had an aggregate amount at risk (the difference between the amount loaned to the Company, including interest payable and securities posted by the counterparty (if any), and the fair value of securities and cash pledged (if any),
including accrued interest on such securities) with all counterparties of approximately $155.8 million. The Company did not have an amount at risk with any individual counterparty greater than 10% of the Company’s equity at March 31, 2020 and
December 31, 2019.
11
NOTE 4. DERIVATIVE FINANCIAL INSTRUMENTS
Derivative Assets (Liabilities), at Fair Value
The table below summarizes fair value information about our derivative assets and liabilities as of March 31, 2020 and December 31, 2019.
(in thousands)
|
|||||||||
Derivative Instruments and Related Accounts
|
Balance Sheet Location
|
March 31, 2020
|
December 31, 2019
|
||||||
Assets
|
|||||||||
Payer swaptions
|
Derivative assets, at fair value
|
$
|
1,336
|
$
|
-
|
||||
Total derivative assets, at fair value
|
$
|
1,336
|
$
|
-
|
|||||
Liabilities
|
|||||||||
Interest rate swaps
|
Derivative liabilities, at fair value
|
$
|
30,097
|
$
|
20,146
|
||||
TBA securities
|
Derivative liabilities, at fair value
|
-
|
512
|
||||||
Total derivative liabilities, at fair value
|
$
|
30,097
|
$
|
20,658
|
|||||
Margin Balances Posted to (from) Counterparties
|
|||||||||
Futures contracts
|
Restricted cash
|
$
|
898
|
$
|
1,338
|
||||
TBA securities
|
Restricted cash
|
-
|
246
|
||||||
Interest rate swap contracts
|
Restricted cash
|
15,588
|
17,450
|
||||||
Total margin balances on derivative contracts
|
$
|
16,486
|
$
|
19,034
|
Eurodollar, Fed Funds and T-Note futures are cash settled futures contracts on an interest rate, with gains and losses credited or charged to the Company’s cash accounts on a daily basis. A minimum balance, or “margin”,
is required to be maintained in the account on a daily basis. The tables below present information related to the Company’s Eurodollar and T-Note futures positions at March 31, 2020 and December 31, 2019.
($ in thousands)
|
||||||||||||||||
March 31, 2020
|
||||||||||||||||
Average
|
Weighted
|
Weighted
|
||||||||||||||
Contract
|
Average
|
Average
|
||||||||||||||
Notional
|
Entry
|
Effective
|
Open
|
|||||||||||||
Expiration Year
|
Amount
|
Rate
|
Rate
|
Equity(1)
|
||||||||||||
Eurodollar Futures Contracts (Short Positions)
|
||||||||||||||||
2020
|
$
|
50,000
|
3.24
|
%
|
0.41
|
%
|
$
|
(1,064
|
)
|
|||||||
2021
|
50,000
|
1.03
|
%
|
0.30
|
%
|
(362
|
)
|
|||||||||
Total / Weighted Average
|
$
|
50,000
|
1.98
|
%
|
0.35
|
%
|
$
|
(1,426
|
)
|
|||||||
Treasury Note Futures Contracts (Short Position)(2)
|
||||||||||||||||
June 2020 5-year T-Note futures
|
||||||||||||||||
(Jun 2020 - Jun 2025 Hedge Period)
|
$
|
69,000
|
1.57
|
%
|
0.81
|
%
|
$
|
(3,175
|
)
|
12
($ in thousands)
|
||||||||||||||||
December 31, 2019
|
||||||||||||||||
Average
|
Weighted
|
Weighted
|
||||||||||||||
Contract
|
Average
|
Average
|
||||||||||||||
Notional
|
Entry
|
Effective
|
Open
|
|||||||||||||
Expiration Year
|
Amount
|
Rate
|
Rate
|
Equity(1)
|
||||||||||||
Eurodollar Futures Contracts (Short Positions)
|
||||||||||||||||
2020
|
$
|
500,000
|
2.97
|
%
|
1.67
|
%
|
$
|
(6,505
|
)
|
|||||||
Total / Weighted Average
|
$
|
500,000
|
2.97
|
%
|
1.67
|
%
|
$
|
(6,505
|
)
|
|||||||
Treasury Note Futures Contracts (Short Position)(2)
|
||||||||||||||||
March 2020 5 year T-Note futures
|
||||||||||||||||
(Mar 2020 - Mar 2025 Hedge Period)
|
$
|
69,000
|
1.96
|
%
|
2.06
|
%
|
$
|
302
|
(1)
|
Open equity represents the cumulative gains (losses) recorded on open futures positions from inception.
|
(2)
|
T-Note futures contracts were valued at a price of $125.36 at March 31, 2020 and $118.61 at December 31, 2019. The notional contract values of the short positions were $86.5 million and $81.8 million at March 31, 2020 and December 31,
2019, respectively.
|
Under our interest rate swap agreements, we typically pay a fixed rate and receive a floating rate based on the London Interbank Offered Rate (“LIBOR”) ("payer swaps"). The floating rate we receive under our swap
agreements has the effect of offsetting the repricing characteristics of our repurchase agreements and cash flows on such liabilities. We are typically required to post collateral on our interest rate swap agreements. The table below presents
information related to the Company’s interest rate swap positions at March 31, 2020 and December 31, 2019.
($ in thousands)
|
||||||||||||||||||||
Average
|
Net
|
|||||||||||||||||||
Fixed
|
Average
|
Estimated
|
Average
|
|||||||||||||||||
Notional
|
Pay
|
Receive
|
Fair
|
Maturity
|
||||||||||||||||
Amount
|
Rate
|
Rate
|
Value
|
(Years)
|
||||||||||||||||
March 31, 2020
|
||||||||||||||||||||
Expiration > 3 to ≤ 5 years
|
$
|
625,000
|
1.65
|
%
|
1.74
|
%
|
$
|
(30,097
|
)
|
4.2
|
||||||||||
$
|
625,000
|
1.65
|
%
|
1.74
|
%
|
$
|
(30,097
|
)
|
4.2
|
|||||||||||
December 31, 2019
|
||||||||||||||||||||
Expiration > 1 to ≤ 3 years
|
$
|
360,000
|
2.05
|
%
|
1.90
|
%
|
$
|
(3,680
|
)
|
2.3
|
||||||||||
Expiration > 3 to ≤ 5 years
|
910,000
|
2.03
|
%
|
1.93
|
%
|
(16,466
|
)
|
4.4
|
||||||||||||
$
|
1,270,000
|
2.03
|
%
|
1.92
|
%
|
$
|
(20,146
|
)
|
3.8
|
The table below presents information related to the Company’s interest rate swaption positions at March 31, 2020. There were no open swaption positions at December 31, 2019.
($ in thousands)
|
||||||||
Option
|
Underlying Swap
|
|||||||
Weighted
|
Average
|
Weighted
|
||||||
Average
|
Average
|
Adjustable
|
Average
|
|||||
Fair
|
Months to
|
Notional
|
Fixed
|
Rate
|
Term
|
|||
Expiration
|
Cost
|
Value
|
Expiration
|
Amount
|
Rate
|
(LIBOR)
|
(Years)
|
|
March 31, 2020
|
||||||||
≤ 1 year
|
||||||||
Payer Swaptions
|
$3,925
|
$1,336
|
8.0
|
$750,000
|
1.22%
|
3 Month
|
4.3
|
13
The following table summarizes our contracts to purchase and sell TBA securities as of December 31, 2019. There were no open TBA securities positions at March 31, 2020.
($ in thousands)
|
|||||||||||||||||||
Notional
|
Net
|
||||||||||||||||||
Amount
|
Cost
|
Market
|
Carrying
|
||||||||||||||||
Long (Short)(1)
|
Basis(2)
|
Value(3)
|
Value(4)
|
||||||||||||||||
December 31, 2019
|
|||||||||||||||||||
30-Year TBA securities:
|
|||||||||||||||||||
4.5
|
%
|
$
|
(300,000
|
)
|
$
|
(315,426
|
)
|
$
|
(315,938
|
)
|
$
|
(512
|
)
|
||||||
Total
|
$
|
(300,000
|
)
|
$
|
(315,426
|
)
|
$
|
(315,938
|
)
|
$
|
(512
|
)
|
(1)
|
Notional amount represents the par value (or principal balance) of the underlying Agency RMBS.
|
(2)
|
Cost basis represents the forward price to be paid (received) for the underlying Agency RMBS.
|
(3)
|
Market value represents the current market value of the TBA securities (or of the underlying Agency RMBS) as of period-end.
|
(4)
|
Net carrying value represents the difference between the market value and the cost basis of the TBA securities as of period-end and is reported in derivative assets (liabilities) at fair value in our balance sheets.
|
Gain (Loss) From Derivative Instruments, Net
The table below presents the effect of the Company’s derivative financial instruments on the statements of operations for the three months ended March 31, 2020 and 2019.
(in thousands)
|
||||||||
Three Months Ended March 31,
|
||||||||
2020
|
2019
|
|||||||
Eurodollar futures contracts (short positions)
|
$
|
(8,217
|
)
|
$
|
(10,041
|
)
|
||
T-Note futures contracts (short position)
|
(4,339
|
)
|
(1,677
|
)
|
||||
Interest rate swaps
|
(60,623
|
)
|
(2,295
|
)
|
||||
Payer swaptions
|
(2,589
|
)
|
(378
|
)
|
||||
Net TBA securities
|
(7,090
|
)
|
(4,641
|
)
|
||||
Total
|
$
|
(82,858
|
)
|
$
|
(19,032
|
)
|
Credit Risk-Related Contingent Features
The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the
contracts. We minimize this risk by limiting our counterparties for instruments which are not centrally cleared on a registered exchange to major financial institutions with acceptable credit ratings and monitoring positions with individual
counterparties. In addition, we may be required to pledge assets as collateral for our derivatives, whose amounts vary over time based on the market value, notional amount and remaining term of the derivative contract. In the event of a default by a
counterparty, we may not receive payments provided for under the terms of our derivative agreements, and may have difficulty obtaining our assets pledged as collateral for our derivatives. The cash and cash equivalents pledged as collateral for our
derivative instruments are included in restricted cash on our balance sheets. It is the Company's policy not to offset assets and liabilities associated with open derivative contracts. However, the Chicago Mercantile Exchange (“CME”) rules
characterize variation margin transfers as settlement payments, as opposed to adjustments to collateral. As a result, derivative assets and liabilities associated with centrally cleared derivatives for which the CME serves as the central clearing
party are presented as if these derivatives had been settled as of the reporting date.
14
NOTE 5. PLEDGED ASSETS
Assets Pledged to Counterparties
The table below summarizes our assets pledged as collateral under our repurchase agreements and derivative agreements by type, including securities pledged related to securities sold but not yet settled, as of March 31,
2020 and December 31, 2019.
(in thousands)
|
||||||||||||||||||||||||
March 31, 2020
|
December 31, 2019
|
|||||||||||||||||||||||
Repurchase
|
Derivative
|
Repurchase
|
Derivative
|
|||||||||||||||||||||
Assets Pledged to Counterparties
|
Agreements
|
Agreements
|
Total
|
Agreements
|
Agreements
|
Total
|
||||||||||||||||||
PT RMBS - fair value
|
$
|
2,900,536
|
$
|
-
|
$
|
2,900,536
|
$
|
3,500,394
|
$
|
-
|
$
|
3,500,394
|
||||||||||||
Structured RMBS - fair value
|
37,213
|
-
|
37,213
|
83,960
|
-
|
83,960
|
||||||||||||||||||
Accrued interest on pledged securities
|
9,853
|
-
|
9,853
|
12,367
|
-
|
12,367
|
||||||||||||||||||
Restricted cash
|
22,239
|
16,486
|
38,725
|
65,851
|
19,034
|
84,885
|
||||||||||||||||||
Total
|
$
|
2,969,841
|
$
|
16,486
|
$
|
2,986,327
|
$
|
3,662,572
|
$
|
19,034
|
$
|
3,681,606
|
Assets Pledged from Counterparties
The table below summarizes our assets pledged to us from counterparties under our repurchase agreements and derivative agreements as of March 31, 2020 and December 31, 2019.
(in thousands)
|
||||||||||||||||||||||||
March 31, 2020
|
December 31, 2019
|
|||||||||||||||||||||||
Repurchase
|
Derivative
|
Repurchase
|
Derivative
|
|||||||||||||||||||||
Assets Pledged to Orchid
|
Agreements
|
Agreements
|
Total
|
Agreements
|
Agreements
|
Total
|
||||||||||||||||||
Cash
|
$
|
427
|
$
|
-
|
$
|
427
|
$
|
1,418
|
$
|
-
|
$
|
1,418
|
||||||||||||
Total
|
$
|
427
|
$
|
-
|
$
|
427
|
$
|
1,418
|
$
|
-
|
$
|
1,418
|
RMBS and U.S. Treasury securities received as margin under our repurchase agreements are not recorded in the balance sheets because the counterparty retains ownership of the security. Cash received as margin is
recognized in cash and cash equivalents with a corresponding amount recognized as an increase in repurchase agreements or other liabilities in the balance sheets.
NOTE 6. OFFSETTING ASSETS AND LIABILITIES
The Company’s derivatives and repurchase agreements are subject to underlying agreements with master netting or similar arrangements, which provide for the right of offset in the event of default or in the event of
bankruptcy of either party to the transactions. The Company reports its assets and liabilities subject to these arrangements on a gross basis.
15
The following table presents information regarding those assets and liabilities subject to such arrangements as if the Company had presented them on a net basis as of March 31, 2020 and December 31, 2019.
(in thousands)
|
||||||||||||
Offsetting of Assets
|
||||||||||||
Gross Amount Not
|
||||||||||||
Net Amount
|
Offset in the Balance Sheet
|
|||||||||||
of Assets
|
Financial
|
|||||||||||
Gross Amount
|
Gross Amount
|
Presented
|
Instruments
|
Cash
|
||||||||
of Recognized
|
Offset in the
|
in the
|
Received as
|
Received as
|
Net
|
|||||||
Assets
|
Balance Sheet
|
Balance Sheet
|
Collateral
|
Collateral
|
Amount
|
|||||||
March 31, 2020
|
||||||||||||
Interest rate swaptions
|
|
$1,336
|
|
$-
|
|
$1,336
|
|
$-
|
|
$-
|
|
$1,336
|
|
$1,336
|
|
$-
|
|
$1,336
|
|
$-
|
|
$-
|
|
$1,336
|
(in thousands)
|
||||||||||||||||||||||||
Offsetting of Liabilities
|
||||||||||||||||||||||||
Gross Amount Not
|
||||||||||||||||||||||||
Net Amount
|
Offset in the Balance Sheet
|
|||||||||||||||||||||||
of Liabilities
|
Financial
|
|||||||||||||||||||||||
Gross Amount
|
Gross Amount
|
Presented
|
Instruments
|
|||||||||||||||||||||
of Recognized
|
Offset in the
|
in the
|
Posted as
|
Cash Posted
|
Net
|
|||||||||||||||||||
Liabilities
|
Balance Sheet
|
Balance Sheet
|
Collateral
|
as Collateral
|
Amount
|
|||||||||||||||||||
March 31, 2020
|
||||||||||||||||||||||||
Repurchase Agreements
|
$
|
2,810,250
|
$
|
-
|
$
|
2,810,250
|
$
|
(2,788,011
|
)
|
$
|
(22,239
|
)
|
$
|
-
|
||||||||||
Interest rate swaps
|
30,097
|
-
|
30,097
|
-
|
(15,588
|
)
|
14,509
|
|||||||||||||||||
$
|
2,840,347
|
$
|
-
|
$
|
2,840,347
|
$
|
(2,788,011
|
)
|
$
|
(37,827
|
)
|
$
|
14,509
|
|||||||||||
December 31, 2019
|
||||||||||||||||||||||||
Repurchase Agreements
|
$
|
3,448,106
|
$
|
-
|
$
|
3,448,106
|
$
|
(3,382,255
|
)
|
$
|
(65,851
|
)
|
$
|
-
|
||||||||||
Interest rate swaps
|
20,146
|
-
|
20,146
|
-
|
(17,450
|
)
|
2,696
|
|||||||||||||||||
TBA securities
|
512
|
-
|
512
|
-
|
(246
|
)
|
266
|
|||||||||||||||||
$
|
3,468,764
|
$
|
-
|
$
|
3,468,764
|
$
|
(3,382,255
|
)
|
$
|
(83,547
|
)
|
$
|
2,962
|
The amounts disclosed for collateral received by or posted to the same counterparty up to and not exceeding the net amount of the asset or liability presented in the balance sheets. The fair value of the actual
collateral received by or posted to the same counterparty typically exceeds the amounts presented. See Note 5 for a discussion of collateral posted or received against or for repurchase obligations and derivative instruments.
16
NOTE 7. CAPITAL STOCK
Common Stock Issuances
During 2020 and 2019, the Company completed the following public offerings of shares of its common stock.
($ in thousands, except per share amounts)
|
|||||||||||||
Weighted
|
|||||||||||||
Average
|
|||||||||||||
Price
|
|||||||||||||
Received
|
Net
|
||||||||||||
Type of Offering
|
Period
|
Per Share(1)
|
Shares
|
Proceeds(2)
|
|||||||||
2020
|
|||||||||||||
At the Market Offering Program(3)
|
First Quarter
|
$
|
6.23
|
3,170,727
|
$
|
19,447
|
|||||||
Total
|
3,170,727
|
$
|
19,447
|
||||||||||
2019
|
|||||||||||||
At the Market Offering Program(3)
|
First Quarter
|
$
|
6.84
|
1,267,894
|
$
|
8,503
|
|||||||
At the Market Offering Program(3)
|
Second Quarter
|
6.70
|
4,337,931
|
28,495
|
|||||||||
At the Market Offering Program(3)
|
Third Quarter
|
6.37
|
1,771,301
|
11,098
|
|||||||||
Follow-on Offering
|
Third Quarter
|
6.35
|
7,000,000
|
44,218
|
|||||||||
14,377,126
|
$
|
92,314
|
(1)
|
Weighted average price received per share is before deducting the underwriters’ discount, if applicable, and other offering costs.
|
(2)
|
Net proceeds are net of the underwriters’ discount, if applicable, and other offering costs.
|
(3)
|
The Company has entered into seven equity distribution agreements, six of which have either been terminated because all shares were sold or were replaced with a subsequent agreement.
|
Stock Repurchase Program
On July 29, 2015, the Company’s Board of Directors authorized the repurchase of up to 2,000,000 shares of the Company’s common stock. On February 8, 2018, the Board of Directors approved an increase in the stock
repurchase program for up to an additional 4,522,822 shares of the Company's common stock. Coupled with the 783,757 shares remaining from the original 2,0000,000 share authorization, the increased authorization brought the total authorization to
5,306,579 shares, representing 10% of the then outstanding share count. As part of the stock repurchase program, shares may be purchased in open market transactions, block purchases, through privately negotiated transactions, or pursuant to any
trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Open market repurchases will be made in accordance with Exchange Act Rule 10b-18, which sets certain
restrictions on the method, timing, price and volume of open market stock repurchases. The timing, manner, price and amount of any repurchases will be determined by the Company in its discretion and will be subject to economic and market conditions,
stock price, applicable legal requirements and other factors. The authorization does not obligate the Company to acquire any particular amount of common stock and the program may be suspended or discontinued at the Company’s discretion without prior
notice.
From the inception of the stock repurchase program through March 31, 2020, the Company repurchased a total of 5,665,620 shares at an aggregate cost of approximately $40.3 million, including commissions and fees, for a
weighted average price of $7.11 per share. During the three months ended March 31, 2019, the Company repurchased a total of 469,975 shares at an aggregate cost of approximately $3.0 million, including commissions and fees, for a weighted average
price of $6.43 per share. The Company did not repurchase any shares of its common stock during the three months ended March 31, 2020. The remaining authorization under the repurchase program as of March 31, 2020 was 857,202 shares.
17
Cash Dividends
The table below presents the cash dividends declared on the Company’s common stock.
(in thousands, except per share amounts)
|
||||||||
Year
|
Per Share Amount
|
Total
|
||||||
2013
|
$
|
1.395
|
$
|
4,662
|
||||
2014
|
2.160
|
22,643
|
||||||
2015
|
1.920
|
38,748
|
||||||
2016
|
1.680
|
41,388
|
||||||
2017
|
1.680
|
70,717
|
||||||
2018
|
1.070
|
55,814
|
||||||
2019
|
0.960
|
54,421
|
||||||
2020 - YTD(1)
|
0.295
|
19,322
|
||||||
Totals
|
$
|
11.160
|
$
|
307,715
|
(1)
|
On April 8, 2020, the Company declared a dividend of $0.055 per share to be paid on May 27, 2020. The effect of this dividend is included in the table above, but is not reflected in the Company’s financial statements as of March 31,
2020.
|
NOTE 8. STOCK INCENTIVE PLAN
In October 2012, the Company’s Board of Directors adopted and Bimini, then the Company’s sole stockholder, approved, the Orchid Island Capital, Inc. 2012 Equity Incentive Plan (the “Incentive Plan”) to recruit and retain
employees, directors and other service providers, including employees of the Manager and other affiliates. The Incentive Plan provides for the award of stock options, stock appreciation rights, stock award, performance units, other equity-based
awards (and dividend equivalents with respect to awards of performance units and other equity-based awards) and incentive awards. The Incentive Plan is administered by the Compensation Committee of the Company’s Board of Directors except that the
Company’s full Board of Directors will administer awards made to directors who are not employees of the Company or its affiliates. The Incentive Plan provides for awards of up to an aggregate of 10% of the issued and outstanding shares of our common
stock (on a fully diluted basis) at the time of the awards, subject to a maximum aggregate 4,000,000 shares of the Company’s common stock that may be issued under the Incentive Plan.
Performance Units
The Company has issued, and may in the future issue additional, performance units under the Incentive Plan to certain executive officers and employees of its Manager. “Performance Units” vest after the end of a defined
performance period, based on satisfaction of the performance conditions set forth in the performance unit agreement. When earned, each Performance Unit will be settled by the issuance of one share of the Company’s common stock, at which time the
Performance Unit will be cancelled. The Performance Units contain dividend equivalent rights, which entitle the Participants to receive distributions declared by the Company on common stock, but do not include the right to vote the shares.
Performance Units are subject to forfeiture should the participant no longer serve as an executive officer or employee of the Company. Compensation expense for the Performance Units is recognized over the remaining vesting period once it becomes
probable that the performance conditions will be achieved.
18
The following table presents information related to Performance Units outstanding during the three months ended March 31, 2020 and 2019.
($ in thousands, except per share data)
|
||||||||||||||||
Three Months Ended March 31,
|
||||||||||||||||
2020
|
2019
|
|||||||||||||||
Weighted
|
Weighted
|
|||||||||||||||
Average
|
Average
|
|||||||||||||||
Grant Date
|
Grant Date
|
|||||||||||||||
Shares
|
Fair Value
|
Shares
|
Fair Value
|
|||||||||||||
Unvested, beginning of period
|
19,021
|
$
|
7.78
|
43,672
|
$
|
8.34
|
||||||||||
Vested and issued
|
(4,153
|
)
|
8.20
|
(8,173
|
)
|
9.08
|
||||||||||
Unvested, end of period
|
14,868
|
$
|
7.66
|
35,499
|
$
|
8.17
|
||||||||||
Compensation expense during period
|
$
|
14
|
$
|
42
|
||||||||||||
Unrecognized compensation expense, end of period
|
$
|
27
|
$
|
115
|
||||||||||||
Intrinsic value, end of period
|
$
|
44
|
$
|
234
|
||||||||||||
Weighted-average remaining vesting term (in years)
|
0.7
|
1.0
|
Deferred Stock Units
Non-employee directors began to receive a portion of their compensation in the form of deferred stock unit awards (“DSUs”) pursuant to the Incentive Plan beginning with the awards for the second quarter of 2018. Each
DSU represents a right to receive one share of the Company’s common stock. The DSUs are immediately vested and are settled at a future date based on the election of the individual participant. The DSUs contain dividend equivalent rights, which
entitle the participant to receive distributions declared by the Company on common stock. These dividend equivalent rights are settled in cash or additional DSUs at the participant’s election. The DSUs do not include the right to vote the underlying
shares of common stock.
The following table presents information related to the DSUs outstanding during the three months ended March 31, 2020 and 2019.
($ in thousands, except per share data)
|
||||||||||||||||
Three Months Ended March 31,
|
||||||||||||||||
2020
|
2019
|
|||||||||||||||
Weighted
|
Weighted
|
|||||||||||||||
Average
|
Average
|
|||||||||||||||
Grant Date
|
Grant Date
|
|||||||||||||||
Shares
|
Fair Value
|
Shares
|
Fair Value
|
|||||||||||||
Outstanding, beginning of period
|
43,570
|
$
|
6.56
|
12,434
|
$
|
7.37
|
||||||||||
Granted and vested
|
9,008
|
5.69
|
7,350
|
6.41
|
||||||||||||
Issued
|
-
|
-
|
-
|
-
|
||||||||||||
Outstanding, end of period
|
52,578
|
$
|
6.41
|
19,784
|
$
|
7.01
|
||||||||||
Compensation expense during period
|
$
|
45
|
$
|
45
|
||||||||||||
Intrinsic value, end of period
|
$
|
155
|
$
|
130
|
NOTE 9. COMMITMENTS AND CONTINGENCIES
From time to time, the Company may become involved in various claims and legal actions arising in the ordinary course of business. Management is not aware of any reported or unreported contingencies at March 31, 2020.
19
NOTE 10. INCOME TAXES
The Company will generally not be subject to federal income tax on its REIT taxable income to the extent that it distributes its REIT taxable income to its stockholders and satisfies the ongoing REIT requirements,
including meeting certain asset, income and stock ownership tests. A REIT must generally distribute at least 90% of its REIT taxable income to its stockholders, of which 85% generally must be distributed within the taxable year, in order to avoid the
imposition of an excise tax. The remaining balance may be distributed up to the end of the following taxable year, provided the REIT elects to treat such amount as a prior year distribution and meets certain other requirements.
NOTE 11. EARNINGS PER SHARE (EPS)
The Company had dividend eligible Performance Units and Deferred Stock Units that were outstanding during the three months ended March 31, 2020 and 2019. The basic and diluted per share computations include these
unvested Performance Units and Deferred Stock Units if there is income available to common stock, as they have dividend participation rights. The unvested Performance Units and Deferred Stock Units have no contractual obligation to share in losses.
Because there is no such obligation, the unvested Performance Units and Deferred Stock Units are not included in the basic and diluted EPS computations when no income is available to common stock even though they are considered participating
securities.
The table below reconciles the numerator and denominator of EPS for the three months ended March 31, 2020 and 2019.
(in thousands, except per share information)
|
||||||||
Three Months Ended March 31,
|
||||||||
2020
|
2019
|
|||||||
Basic and diluted EPS per common share:
|
||||||||
Numerator for basic and diluted EPS per share of common stock:
|
||||||||
Net (loss) income - Basic and diluted
|
$
|
(91,199
|
)
|
$
|
10,597
|
|||
Weighted average shares of common stock:
|
||||||||
Shares of common stock outstanding at the balance sheet date
|
66,237
|
49,938
|
||||||
Unvested dividend eligible share based compensation
|
||||||||
outstanding at the balance sheet date
|
-
|
55
|
||||||
Effect of weighting
|
(1,647
|
)
|
(1,088
|
)
|
||||
Weighted average shares-basic and diluted
|
64,590
|
48,905
|
||||||
Net (loss) income per common share:
|
||||||||
Basic and diluted
|
$
|
(1.41
|
)
|
$
|
0.22
|
|||
Anti-dilutive incentive shares not included in calculation.
|
67
|
-
|
NOTE 12. FAIR VALUE
The framework for using fair value to measure assets and liabilities defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price). A fair value measure should
reflect the assumptions that market participants would use in pricing the asset or liability, including the assumptions about the risk inherent in a particular valuation technique, the effect of a restriction on the sale or use of an asset and the
risk of non-performance. Required disclosures include stratification of balance sheet amounts measured at fair value based on inputs the Company uses to derive fair value measurements. These stratifications are:
•
|
Level 1 valuations, where the valuation is based on quoted market prices for identical assets or liabilities traded in active markets (which include exchanges and over-the-counter markets with sufficient volume),
|
•
|
Level 2 valuations, where the valuation is based on quoted market prices for similar instruments traded in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation
techniques for which all significant assumptions are observable in the market, and
|
20
•
|
Level 3 valuations, where the valuation is generated from model-based techniques that use significant assumptions not observable in the market, but observable based on Company-specific data. These unobservable assumptions reflect the
Company’s own estimates for assumptions that market participants would use in pricing the asset or liability. Valuation techniques typically include option pricing models, discounted cash flow models and similar techniques, but may also
include the use of market prices of assets or liabilities that are not directly comparable to the subject asset or liability.
|
The Company's RMBS, interest rate swaps, interest rate swaptions and TBA securities are valued using Level 2 valuations, and such valuations currently are determined by the Company based on independent pricing sources
and/or third party broker quotes, when available. Because the price estimates may vary, the Company must make certain judgments and assumptions about the appropriate price to use to calculate the fair values. The Company and the independent pricing
sources use various valuation techniques to determine the price of the Company’s securities. These techniques include observing the most recent market for like or identical assets, spread pricing techniques (option adjusted spread, zero volatility
spread, spread to the U.S. Treasury curve or spread to a benchmark such as a TBA), and model driven approaches (the discounted cash flow method, Black Scholes and SABR models which rely upon observable market rates such as the term structure of
interest rates and volatility). The appropriate spread pricing method used is based on market convention. The pricing source determines the spread of recently observed trade activity or observable markets for assets similar to those being priced. The
spread is then adjusted based on variances in certain characteristics between the market observation and the asset being priced. Those characteristics include: type of asset, the expected life of the asset, the stability and predictability of the
expected future cash flows of the asset, whether the coupon of the asset is fixed or adjustable, the guarantor of the security if applicable, the coupon, the maturity, the issuer, size of the underlying loans, year in which the underlying loans were
originated, loan to value ratio, state in which the underlying loans reside, credit score of the underlying borrowers and other variables if appropriate. The fair value of the security is determined by using the adjusted spread.
RMBS (based on the fair value option), interest rate swaps, interest rate swaptions, TBA securities and futures contracts were recorded at fair value on a recurring basis during the three months ended March 31, 2020 and
2019. When determining fair value measurements, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset. When possible, the Company
looks to active and observable markets to price identical assets. When identical assets are not traded in active markets, the Company looks to market observable data for similar assets.
The following table presents financial assets (liabilities) measured at fair value on a recurring basis as of March 31, 2020 and December 31, 2019. Derivative contracts are reported as a net position by contract type,
and not based on master netting arrangements.
(in thousands)
|
||||||||||||||||
Quoted Prices
|
||||||||||||||||
in Active
|
Significant
|
|||||||||||||||
Markets for
|
Other
|
Significant
|
||||||||||||||
Identical
|
Observable
|
Unobservable
|
||||||||||||||
Fair Value
|
Assets
|
Inputs
|
Inputs
|
|||||||||||||
Measurements
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
|||||||||||||
March 31, 2020
|
||||||||||||||||
Mortgage-backed securities
|
$
|
2,948,797
|
$
|
-
|
$
|
2,948,797
|
$
|
-
|
||||||||
Interest rate swaps
|
(30,097
|
)
|
-
|
(30,097
|
)
|
-
|
||||||||||
Interest rate swaptions
|
1,336
|
-
|
1,336
|
-
|
||||||||||||
December 31, 2019
|
||||||||||||||||
Mortgage-backed securities
|
$
|
3,590,921
|
$
|
-
|
$
|
3,590,921
|
$
|
-
|
||||||||
Interest rate swaps
|
(20,146
|
)
|
-
|
(20,146
|
)
|
-
|
||||||||||
TBA securities
|
(512
|
)
|
-
|
(512
|
)
|
-
|
During the three months ended March 31, 2020 and 2019, there were no transfers of financial assets or liabilities between levels 1, 2 or 3.
21
NOTE 13. RELATED PARTY TRANSACTIONS
Management Agreement
The Company is externally managed and advised by Bimini Advisors, LLC (the “Manager”) pursuant to the terms of a management agreement. The management agreement has been renewed through February 20, 2021 and provides for
automatic one-year extension options thereafter and is subject to certain termination rights. Under the terms of the management agreement, the Manager is responsible for administering the business activities and day-to-day operations of the
Company. The Manager receives a monthly management fee in the amount of:
•
|
One-twelfth of 1.5% of the first $250 million of the Company’s month-end equity, as defined in the management agreement,
|
•
|
One-twelfth of 1.25% of the Company’s month-end equity that is greater than $250 million and less than or equal to $500 million, and
|
•
|
One-twelfth of 1.00% of the Company’s month-end equity that is greater than $500 million.
|
The Company is obligated to reimburse the Manager for any direct expenses incurred on its behalf and to pay the Manager the Company’s pro rata portion of certain overhead costs set forth in the management agreement.
Should the Company terminate the management agreement without cause, it will pay the Manager a termination fee equal to three times the average annual management fee, as defined in the management agreement, before or on the last day of the term of
the agreement.
Total expenses recorded for the management fee and costs incurred were approximately $1.7 million and $1.6 million for the three months ended March 31, 2020 and 2019, respectively. At March 31, 2020 and December 31,
2019, the net amount due to affiliates was approximately $0.5 million and $0.6 million, respectively.
Other Relationships with Bimini
Robert Cauley, our Chief Executive Officer and Chairman of our Board of Directors, also serves as Chief Executive Officer and Chairman of the Board of Directors of Bimini and owns shares of common stock of Bimini.
George H. Haas, IV, our Chief Financial Officer, Chief Investment Officer, Secretary and a member of our Board of Directors, also serves as the Chief Financial Officer, Chief Investment Officer and Treasurer of Bimini and owns shares of common stock
of Bimini. In addition, as of March 31, 2020, Bimini owned 1,520,036 shares, or 2.3%, of the Company’s common stock.
22
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and notes to those statements included in Item 1 of this Form 10-Q. The discussion
may contain certain forward-looking statements that involve risks and uncertainties. Forward-looking statements are those that are not historical in nature. As a result of many factors, such as those set forth under “Risk Factors” in our most recent
Annual Report on Form 10-K and this quarterly report on Form 10-Q, our actual results may differ materially from those anticipated in such forward-looking statements.
Overview
We are a specialty finance company that invests in residential mortgage-backed securities (“RMBS”) which are issued and guaranteed by a federally chartered corporation or agency (“Agency RMBS”). Our investment strategy
focuses on, and our portfolio consists of, two categories of Agency RMBS: (i) traditional pass-through Agency RMBS, such as mortgage pass-through certificates issued by Fannie Mae, Freddie Mac or Ginnie Mae (the “GSEs”) and collateralized mortgage
obligations (“CMOs”) issued by the GSEs (“PT RMBS”) and (ii) structured Agency RMBS, such as interest-only securities (“IOs”), inverse interest-only securities (“IIOs”) and principal only securities (“POs”), among other types of structured Agency
RMBS. We were formed by Bimini in August 2010, commenced operations on November 24, 2010 and completed our initial public offering (“IPO”) on February 20, 2013. We are externally managed by Bimini Advisors, an investment adviser registered with the
Securities and Exchange Commission (the “SEC”).
Our business objective is to provide attractive risk-adjusted total returns over the long term through a combination of capital appreciation and the payment of regular monthly distributions. We intend to achieve this
objective by investing in and strategically allocating capital between the two categories of Agency RMBS described above. We seek to generate income from (i) the net interest margin on our leveraged PT RMBS portfolio and the leveraged portion of our
structured Agency RMBS portfolio, and (ii) the interest income we generate from the unleveraged portion of our structured Agency RMBS portfolio. We intend to fund our PT RMBS and certain of our structured Agency RMBS through short-term borrowings
structured as repurchase agreements. PT RMBS and structured Agency RMBS typically exhibit materially different sensitivities to movements in interest rates. Declines in the value of one portfolio may be offset by appreciation in the other. The
percentage of capital that we allocate to our two Agency RMBS asset categories will vary and will be actively managed in an effort to maintain the level of income generated by the combined portfolios, the stability of that income stream and the
stability of the value of the combined portfolios. We believe that this strategy will enhance our liquidity, earnings, book value stability and asset selection opportunities in various interest rate environments.
We operate so as to qualify to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). We generally will not be subject to U.S. federal income tax to the
extent that we currently distribute all of our REIT taxable income (as defined in the Code) to our stockholders and maintain our REIT qualification.
The Company’s common stock trades on the New York Stock Exchange under the symbol “ORC”.
Impact of the COVID-19 Pandemic
Beginning in March 2020, the global pandemic associated with the novel coronavirus COVID-19 (“COVID-19”) and related economic conditions began to impact our financial position and results of operations. As a result of
the economic, health and market turmoil brought about by COVID-19, the Agency RMBS market experienced severe dislocations. This resulted in falling prices of our assets and increased margin calls from our repurchase agreement lenders. In order to
maintain sufficient cash and liquidity, reduce risk and satisfy margin calls, we were forced to sell assets at levels significantly below their carrying values. We timely satisfied all margin calls. The Agency RMBS market largely stabilized after the
Federal Reserve announced on March 23, 2020 that it would purchase Agency RMBS and U.S. Treasuries in the amounts needed to support smooth market functioning. The following summarizes the impact COVID-19 has had on our financial position and results
of operations through March 31, 2020.
23
•
|
We sold approximately $1.8 billion of RMBS during the three months ended March 31, 2020, realizing losses of approximately $28.4 million. Approximately $1.1 billion of these sales were executed on
March 19th and March 20th and resulted in losses of approximately $31.4 million. The losses sustained on these two days were a direct result of the adverse RMBS market conditions associated with COVID-19.
|
•
|
We terminated interest rate swap positions with an aggregate notional value of $860.0 million and incurred approximately $45.0 million in mark to market losses on the positions through the date of the respective terminations.
|
•
|
Our RMBS portfolio had a fair market value of approximately $2.9 billion as of March 31, 2020, compared to $3.6 billion as of December 31, 2019.
|
•
|
Our outstanding balances under our repurchase agreement borrowings as of March 31, 2020 were approximately $2.8 billion, compared to $3.4 billion as of December 31, 2019.
|
•
|
Our stockholders’ equity was $308.1 million as of March 31, 2020, compared to $395.5 million as of December 31, 2019.
|
Largely as a result of actions taken by the Federal Reserve (the “Fed”) in late March, Agency RMBS valuations have increased and the market for these assets has stabilized.
Our manager has invoked its Disaster Recovery Plan and its employees are working remotely. Prior planning resulted in the successful implementation of this plan and key operational team members maintain daily
communication. We do not anticipate incurring additional material costs, nor have we identified any operational or internal control issues related to this remote working plan.
Capital Raising Activities
On August 2, 2017, we entered into an equity distribution agreement (the “August 2017 Equity Distribution Agreement”) with two sales agents pursuant to which we could offer and sell, from time to time, up to an aggregate
amount of $125,000,000 of shares of our common stock in transactions that were deemed to be “at the market” offerings and privately negotiated transactions. We issued a total of 15,123,178 shares under the August 2017 Equity Distribution Agreement
for aggregate gross proceeds of $125.0 million, and net proceeds of approximately $123.1 million, net of commissions and fees, prior to its termination in July 2019.
On July 30, 2019, we entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the
underwriters named therein, relating to the offer and sale of 7,000,000 shares of our common stock at a price to the public of $6.55 per share. The underwriters purchased the shares pursuant to the Underwriting Agreement at a price of $6.3535 per
share. The closing of the offering of 7,000,000 shares of common stock occurred on August 2, 2019, with net proceeds to us of approximately $44.2 million after deduction of underwriting discounts and commissions and other estimated offering expenses.
On January 23, 2020, we entered into an equity distribution agreement (the “January 2020 Equity Distribution Agreement”) with three sales agents pursuant to which we may offer and sell, from time to time, up to an
aggregate amount of $200,000,000 of shares of our common stock in transactions that are deemed to be “at the market” offerings and privately negotiated transactions. Through March 31, 2020, we issued a total of 3,170,727 shares under the January
2020 Equity Distribution Agreement for aggregate gross proceeds of $19.8 million, and net proceeds of approximately $19.4 million, net of commissions and fees.
24
Stock Repurchase Agreement
On July 29, 2015, the Company’s Board of Directors authorized the repurchase of up to 2,000,000 shares of our common stock. The timing, manner, price and amount of any repurchases is determined by the Company in its
discretion and is subject to economic and market conditions, stock price, applicable legal requirements and other factors. The authorization does not obligate the Company to acquire any particular amount of common stock and the program may be
suspended or discontinued at the Company’s discretion without prior notice. On February 8, 2018, the Board of Directors approved an increase in the stock repurchase program for up to an additional 4,522,822 shares of the Company’s common stock.
Coupled with the 783,757 shares remaining from the original 2,0000,000 share authorization, the increased authorization brought the total authorization to 5,306,579 shares, representing 10% of the then outstanding share count. This stock repurchase
program has no termination date.
From the inception of the stock repurchase program through March 31, 2020, the Company repurchased a total of 5,665,620 shares at an aggregate cost of approximately $40.3 million, including commissions and fees, for a
weighted average price of $7.11 per share. The Company did not repurchase any shares of its common stock during the three months ended March 31, 2020. The remaining authorization under the repurchase program as of March 31, 2020 was 857,202 shares.
Factors that Affect our Results of Operations and Financial Condition
A variety of industry and economic factors may impact our results of operations and financial condition. These factors include:
•
|
interest rate trends;
|
•
|
the difference between Agency RMBS yields and our funding and hedging costs;
|
•
|
competition for, and supply of, investments in Agency RMBS;
|
•
|
actions taken by the U.S. government, including the presidential administration, the Fed, the Federal Housing Financing Agency (the “FHFA”), the Federal Open Market Committee (the “FOMC”) and the U.S. Treasury;
|
•
|
prepayment rates on mortgages underlying our Agency RMBS and credit trends insofar as they affect prepayment rates; and
|
•
|
other market developments.
|
In addition, a variety of factors relating to our business may also impact our results of operations and financial condition. These factors include:
•
|
our degree of leverage;
|
•
|
our access to funding and borrowing capacity;
|
•
|
our borrowing costs;
|
•
|
our hedging activities;
|
•
|
the market value of our investments; and
|
•
|
the requirements to qualify as a REIT and the requirements to qualify for a registration exemption under the Investment Company Act.
|
Results of Operations
Described below are the Company’s results of operations for the three months ended March 31, 2020, as compared to the Company’s results of operations for the three months ended March 31, 2019.
25
Net (Loss) Income Summary
Net loss for the three months ended March 31, 2020 was $91.2 million, or $1.41 per share. Net income for the three months ended March 31, 2019 was $10.6 million, or $0.22 per share. The components of net (loss) income
for the three months ended March 31, 2020 and 2019, along with the changes in those components are presented in the table below:
(in thousands)
|
||||||||||||
2020
|
2019
|
Change
|
||||||||||
Interest income
|
$
|
35,671
|
$
|
32,433
|
$
|
3,238
|
||||||
Interest expense
|
(16,523
|
)
|
(18,892
|
)
|
2,369
|
|||||||
Net interest income
|
19,148
|
13,541
|
5,607
|
|||||||||
Losses on RMBS and derivative contracts
|
(108,206
|
)
|
(748
|
)
|
(107,458
|
)
|
||||||
Net portfolio (deficiency) income
|
(89,058
|
)
|
12,793
|
(101,851
|
)
|
|||||||
Expenses
|
(2,141
|
)
|
(2,196
|
)
|
55
|
|||||||
Net (loss) income
|
$
|
(91,199
|
)
|
$
|
10,597
|
$
|
(101,796
|
)
|
GAAP and Non-GAAP Reconciliations
In addition to the results presented in accordance with GAAP, our results of operations discussed below include certain non-GAAP financial information, including “Net Earnings Excluding Realized and Unrealized Gains and
Losses”, “Economic Interest Expense” and “Economic Net Interest Income.”
Net Earnings Excluding Realized and Unrealized Gains and Losses
We have elected to account for our Agency RMBS under the fair value option. Securities held under the fair value option are recorded at estimated fair value, with changes in the fair value recorded as unrealized gains or
losses through the statements of operations.
In addition, we have not designated our derivative financial instruments in hedge accounting relationships, but rather hold them for economic hedging purposes. Changes in fair value of these instruments are presented in
a separate line item in the Company’s statements of operations and not included in interest expense. As such, for financial reporting purposes, interest expense and cost of funds are not impacted by the fluctuation in value of the derivative
instruments.
Presenting net earnings excluding realized and unrealized gains allows management to: (i) isolate the net interest income and other expenses of the Company over time, free of all fair value adjustments and (ii) assess
the effectiveness of our funding and hedging strategies on our capital allocation decisions and our asset allocation performance. Our funding and hedging strategies, capital allocation and asset selection are integral to our risk management strategy,
and therefore critical to the management of our portfolio. We believe that the presentation of our net earnings excluding realized and unrealized gains is useful to investors because it provides a means of comparing our results of operations to
those of our peers who have not elected the same accounting treatment. Our presentation of net earnings excluding realized and unrealized gains and losses may not be comparable to similarly-titled measures of other companies, who may use different
calculations. As a result, net earnings excluding realized and unrealized gains and losses should not be considered as a substitute for our GAAP net income (loss) as a measure of our financial performance or any measure of our liquidity under GAAP.
The table below presents a reconciliation of our net income (loss) determined in accordance with GAAP and net earnings excluding realized and unrealized gains.
26
Net Earnings Excluding Realized and Unrealized Gains and Losses
|
||||||||||||||||||||||||
(in thousands, except per share data)
|
||||||||||||||||||||||||
Per Share
|
||||||||||||||||||||||||
Net Earnings
|
Net Earnings
|
|||||||||||||||||||||||
Excluding
|
Excluding
|
|||||||||||||||||||||||
Realized and
|
Realized and
|
Realized and
|
Realized and
|
|||||||||||||||||||||
Net
|
Unrealized
|
Unrealized
|
Net
|
Unrealized
|
Unrealized
|
|||||||||||||||||||
Income
|
Gains and
|
Gains and
|
Income
|
Gains and
|
Gains and
|
|||||||||||||||||||
(GAAP)
|
Losses(1)
|
Losses
|
(GAAP)
|
Losses
|
Losses
|
|||||||||||||||||||
Three Months Ended
|
||||||||||||||||||||||||
March 31, 2020
|
$
|
(91,199
|
)
|
$
|
(108,206
|
)
|
$
|
17,007
|
$
|
(1.41
|
)
|
$
|
(1.68
|
)
|
$
|
0.27
|
||||||||
December 31, 2019
|
18,614
|
3,841
|
14,773
|
0.29
|
0.06
|
0.23
|
||||||||||||||||||
September 30, 2019
|
(8,477
|
)
|
(19,429
|
)
|
10,952
|
(0.14
|
)
|
(0.32
|
)
|
0.18
|
||||||||||||||
June 30, 2019
|
3,530
|
(7,672
|
)
|
11,202
|
0.07
|
(0.15
|
)
|
0.22
|
||||||||||||||||
March 31, 2019
|
10,597
|
(748
|
)
|
11,345
|
0.22
|
(0.02
|
)
|
0.24
|
(1)
|
Includes realized and unrealized gains (losses) on RMBS and derivative financial instruments, including net interest income or expense on interest rate swaps.
|
Economic Interest Expense and Economic Net Interest Income
We use derivative instruments, specifically Eurodollar, Fed Funds and Treasury Note (“T-Note”) futures contracts, interest rate swaps and swaptions, to hedge a portion of the interest rate risk on repurchase agreements
in a rising rate environment.
We have not elected to designate our derivative holdings for hedge accounting treatment. Changes in fair value of these instruments are presented in a separate line item in our statements of operations and not included
in interest expense. As such, for financial reporting purposes, interest expense and cost of funds are not impacted by the fluctuation in value of the derivative instruments.
For the purpose of computing economic net interest income and ratios relating to cost of funds measures, GAAP interest expense has been adjusted to reflect the realized and unrealized gains or losses on certain
derivative instruments the Company uses, specifically Eurodollar, Fed Funds and U.S. Treasury futures, and interest rate swaps and swaptions, that pertain to each period presented. We believe that adjusting our interest expense for the periods
presented by the gains or losses on these derivative instruments would not accurately reflect our economic interest expense for these periods. The reason is that these derivative instruments may cover periods that extend into the future, not just the
current period. Any realized or unrealized gains or losses on the instruments reflect the change in market value of the instrument caused by changes in underlying interest rates applicable to the term covered by the instrument, not just the current
period. For each period presented, we have combined the effects of the derivative financial instruments in place for the respective period with the actual interest expense incurred on borrowings to reflect total economic interest expense for the
applicable period. Interest expense, including the effect of derivative instruments for the period, is referred to as economic interest expense. Net interest income, when calculated to include the effect of derivative instruments for the period, is
referred to as economic net interest income. This presentation includes gains or losses on all contracts in effect during the reporting period, covering the current period as well as periods in the future.
We believe that economic interest expense and economic net interest income provide meaningful information to consider, in addition to the respective amounts prepared in accordance with GAAP. The non-GAAP measures help
management to evaluate its financial position and performance without the effects of certain transactions and GAAP adjustments that are not necessarily indicative of our current investment portfolio or operations. The unrealized gains or losses on
derivative instruments presented in our statements of operations are not necessarily representative of the total interest rate expense that we will ultimately realize. This is because as interest rates move up or down in the future, the gains or
losses we ultimately realize, and which will affect our total interest rate expense in future periods, may differ from the unrealized gains or losses recognized as of the reporting date.
27
Our presentation of the economic value of our hedging strategy has important limitations. First, other market participants may calculate economic interest expense and economic net interest income differently than the way
we calculate them. Second, while we believe that the calculation of the economic value of our hedging strategy described above helps to present our financial position and performance, it may be of limited usefulness as an analytical tool. Therefore,
the economic value of our investment strategy should not be viewed in isolation and is not a substitute for interest expense and net interest income computed in accordance with GAAP.
The tables below present a reconciliation of the adjustments to interest expense shown for each period relative to our derivative instruments, and the income statement line item, gains (losses) on derivative instruments,
calculated in accordance with GAAP for each quarter of 2020 to date and 2019.
Gains (Losses) on Derivative Instruments
|
||||||||||||||||
(in thousands)
|
||||||||||||||||
Funding Hedges
|
||||||||||||||||
Recognized in
|
Attributed to
|
Attributed to
|
||||||||||||||
Income
|
TBA
|
Current
|
Future
|
|||||||||||||
Statement
|
Securities
|
Period
|
Periods
|
|||||||||||||
(GAAP)
|
Income (Loss)
|
(Non-GAAP)
|
(Non-GAAP)
|
|||||||||||||
Three Months Ended
|
||||||||||||||||
March 31, 2020
|
$
|
(82,858
|
)
|
$
|
(7,090
|
)
|
$
|
(4,900
|
)
|
$
|
(70,868
|
)
|
||||
December 31, 2019
|
10,792
|
(512
|
)
|
3,823
|
$
|
7,481
|
||||||||||
September 30, 2019
|
(8,648
|
)
|
2,479
|
1,244
|
$
|
(12,371
|
)
|
|||||||||
June 30, 2019
|
(34,288
|
)
|
(1,684
|
)
|
1,464
|
$
|
(34,068
|
)
|
||||||||
March 31, 2019
|
(19,032
|
)
|
(4,641
|
)
|
2,427
|
$
|
(16,818
|
)
|
Economic Interest Expense and Economic Net Interest Income
|
||||||||||||||||||||||||
(in thousands)
|
||||||||||||||||||||||||
Interest Expense on Borrowings
|
||||||||||||||||||||||||
Gains
|
||||||||||||||||||||||||
(Losses) on
|
||||||||||||||||||||||||
Derivative
|
||||||||||||||||||||||||
Instruments
|
Net Interest Income
|
|||||||||||||||||||||||
GAAP
|
Attributed
|
Economic
|
GAAP
|
Economic
|
||||||||||||||||||||
Interest
|
Interest
|
to Current
|
Interest
|
Net Interest
|
Net Interest
|
|||||||||||||||||||
Income
|
Expense
|
Period(1)
|
Expense(2)
|
Income
|
Income(3)
|
|||||||||||||||||||
Three Months Ended
|
||||||||||||||||||||||||
March 31, 2020
|
$
|
35,671
|
$
|
16,523
|
$
|
(4,900
|
)
|
$
|
21,423
|
$
|
19,148
|
$
|
14,248
|
|||||||||||
December 31, 2019
|
37,529
|
20,022
|
3,823
|
16,199
|
17,507
|
21,330
|
||||||||||||||||||
September 30, 2019
|
35,907
|
22,321
|
1,244
|
21,077
|
13,586
|
14,830
|
||||||||||||||||||
June 30, 2019
|
36,455
|
22,431
|
1,464
|
20,967
|
14,024
|
15,488
|
||||||||||||||||||
March 31, 2019
|
32,433
|
18,892
|
2,427
|
16,465
|
13,541
|
15,968
|
(1)
|
Reflects the effect of derivative instrument hedges for only the period presented.
|
(2)
|
Calculated by adding the effect of derivative instrument hedges attributed to the period presented to GAAP interest expense.
|
(3)
|
Calculated by adding the effect of derivative instrument hedges attributed to the period presented to GAAP net interest income.
|
28
Net Interest Income
During the three months ended March 31, 2020, we generated $19.1 million of net interest income, consisting of $35.7 million of interest income from RMBS assets offset by $16.5 million of interest expense on borrowings.
For the comparable period ended March 31, 2019, we generated $13.5 million of net interest income, consisting of $32.4 million of interest income from RMBS assets offset by $18.9 million of interest expense on borrowings. The $3.2 million increase
in interest income was due to the $218.4 million increase in average RMBS, combined with an 11 basis point ("bps") increase in the yield on average RMBS. The $2.4 million decrease in interest expense was due to a 46 bps decrease in the average cost
of funds, partially offset by a $183.3 million increase in average outstanding borrowings. We had more average assets and borrowings during the first quarter of 2020 compared to the first quarter of 2019 as a result of our capital raising activity
during 2019 and the first quarter of 2020.
On an economic basis, our interest expense on borrowings for the three months ended March 31, 2020 and 2019 was $21.4 million and $16.5 million, respectively, resulting in $14.2 million and $16.0 million of economic net
interest income, respectively. The higher economic interest expense during the three months ended March 31, 2020 was due to the negative performance of our hedging activities during the period.
The tables below provide information on our portfolio average balances, interest income, yield on assets, average borrowings, interest expense, cost of funds, net interest income and net interest spread for each quarter
in 2020 and 2019 on both a GAAP and economic basis.
($ in thousands)
|
||||||||||||||||||||||||||||||||
Average
|
Yield on
|
Interest Expense
|
Average Cost of Funds
|
|||||||||||||||||||||||||||||
RMBS
|
Interest
|
Average
|
Average
|
GAAP
|
Economic
|
GAAP
|
Economic
|
|||||||||||||||||||||||||
Held(1)
|
Income
|
RMBS
|
Borrowings(1)
|
Basis
|
Basis(2)
|
Basis
|
Basis(3)
|
|||||||||||||||||||||||||
Three Months Ended
|
||||||||||||||||||||||||||||||||
March 31, 2020
|
$
|
3,269,859
|
$
|
35,671
|
4.36
|
%
|
$
|
3,129,178
|
$
|
16,523
|
$
|
21,423
|
2.11
|
%
|
2.74
|
%
|
||||||||||||||||
December 31, 2019
|
3,705,920
|
37,529
|
4.05
|
%
|
3,631,042
|
20,022
|
16,199
|
2.21
|
%
|
1.78
|
%
|
|||||||||||||||||||||
September 30, 2019
|
3,674,087
|
35,907
|
3.91
|
%
|
3,571,752
|
22,321
|
21,077
|
2.50
|
%
|
2.36
|
%
|
|||||||||||||||||||||
June 30, 2019
|
3,307,885
|
36,455
|
4.41
|
%
|
3,098,133
|
22,431
|
20,967
|
2.90
|
%
|
2.71
|
%
|
|||||||||||||||||||||
March 31, 2019
|
3,051,509
|
32,433
|
4.25
|
%
|
2,945,895
|
18,892
|
16,465
|
2.57
|
%
|
2.24
|
%
|
($ in thousands)
|
||||||||||||||||
Net Interest Income
|
Net Interest Spread
|
|||||||||||||||
GAAP
|
Economic
|
GAAP
|
Economic
|
|||||||||||||
Basis
|
Basis(2)
|
Basis
|
Basis(4)
|
|||||||||||||
Three Months Ended
|
||||||||||||||||
March 31, 2020
|
$
|
19,148
|
$
|
14,248
|
2.25
|
%
|
1.62
|
%
|
||||||||
December 31, 2019
|
17,507
|
21,330
|
1.84
|
%
|
2.27
|
%
|
||||||||||
September 30, 2019
|
13,586
|
14,830
|
1.41
|
%
|
1.55
|
%
|
||||||||||
June 30, 2019
|
14,024
|
15,488
|
1.51
|
%
|
1.70
|
%
|
||||||||||
March 31, 2019
|
13,541
|
15,968
|
1.68
|
%
|
2.01
|
%
|
(1)
|
Portfolio yields and costs of borrowings presented in the tables above and the tables on page 30 are calculated based on the average balances of the underlying investment portfolio/borrowings balances and are annualized for the periods
presented. Average balances for quarterly periods are calculated using two data points, the beginning and ending balances.
|
(2)
|
Economic interest expense and economic net interest income presented in the table above and the tables on page 30 include the effect of our derivative instrument hedges for only the periods presented.
|
(3) |
Represents interest cost of our borrowings and the effect of derivative instrument hedges attributed to the period divided by average RMBS.
|
(4) |
Economic net interest spread is calculated by subtracting average economic cost of funds from realized yield on average RMBS.
|
29
Interest Income and Average Asset Yield
Our interest income for the three months ended March 31, 2020 and 2019 was $35.7 million and $32.4 million, respectively. We had average RMBS holdings of $3,269.9 million and $3,051.5 million for the three months ended
March 31, 2020 and 2019, respectively. The yield on our portfolio was 4.36% and 4.25% for the three months ended March 31, 2020 and 2019, respectively. For the three months ended March 31, 2020 as compared to the three months ended March 31, 2019,
there was a $3.2 million increase in interest income due to a $218.4 million increase in average RMBS, combined with an 11 bps increase in the yield on average RMBS.
The table below presents the average portfolio size, income and yields of our respective sub-portfolios, consisting of structured RMBS and PT RMBS for each quarter in 2020 to date and 2019.
($ in thousands)
|
||||||||||||||||||||||||||||||||||||
Average RMBS Held
|
Interest Income
|
Realized Yield on Average RMBS
|
||||||||||||||||||||||||||||||||||
PT
|
Structured
|
PT
|
Structured
|
PT
|
Structured
|
|||||||||||||||||||||||||||||||
Three Months Ended
|
RMBS
|
RMBS
|
Total
|
RMBS
|
RMBS
|
Total
|